Several studies have shown that high levels of mood regularity (low variability, in other words) are characteristic of disease states particularly in patients with major depression (Katerndahl and Wang 2007), posttraumatic stress disorder (Cowdry et al. 1991), or panic disorder (Katerndahl and Wang 2007).
Aside from post-traumatic stress and dissociation symptoms, a significant number of other mental health and behavioral disturbances have been linked to CSA. High levels of mood disorders, such as major depressive episodes, are found in cohorts of children and teenagers who have been sexually abused [ 56, 57].
The assessment of childhood trauma is particularly required for subgroups of patients with BD with early onset, comorbidity with suicide attempts or substance misuse, high level of mood recurrences or greater mood instability (as a categorical pattern, i.e., rapid cycling or as a dimensional one, i.e., affective lability).
This review points to a high level of mood disorders in oncology and haematology.
During the second body image exposure session, higher levels of mood and appearance self-esteem were observed in both groups, and negative cognitions occurred less frequently.
Still, most of the people who use BZP, even though they say it is quite easy to stop, do not want to, and continue to use the drug, feeling that it helps them to reach higher levels of mood, sociability, and energy.
High levels of mind wandering are related with low moods (Killingsworth and Gilbert, 2010) and negative thinking (Smallwood, O'Connor, Sudbery, and Obonsawin, 2007).
These findings support the use of self-compassion as another adaptive emotion regulation strategy for patients with major depressive disorder, especially for those suffering from high levels of depressed mood.
There was a negative association between YMRS and GAF-F, indicating that patients with high levels of elevated mood had poorer functioning.
A higher level of mood disturbance led to a higher level of symptoms when the level of social support was average or low, which implies that clinical interventions for attenuating the impact of mood disturbance on symptom experience might be effective only for women perceiving average or low levels of social support.
High levels of cortisol can impair mood as well as cause hyperglycemia and insulin resistance and other traits typical of T2D and MetS.
